Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Graft-Versus-Host Disease

Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease

Bone Marrow Transplantation volume 35, pages 1083–1088 (2005)Cite this article

Summary:

Achievement of complete donor hematopoietic chimerism (CC) is the goal of allogeneic stem cell transplantation (allo-SCT). Persistence of recipient hematopoiesis augments the risk of relapse, which is one of the main reasons for mortality after allo-SCT. Another main reason for morbidity and mortality is severe extensive chronic graft-versus-host disease (cGvHD). We examined chimerism in peripheral blood of 54 allogeneic stem cell recipients using multiplex STR-PCR method and compared it with the timing and severity of cGvHD. In total, 25 patients achieved early CC (by day 100 post transplant) at a median time of 60 days. In total, 21 of them developed extensive cGvHD. In those patients CC uniformly preceded emergence of cGvHD by a mean of 85 days. A total of 26 patients obtained late CC at a median time of 270 days post transplant. Of this group, only eight patients developed extensive disease. Development of cGvHD in those patients preceded achievement of CC in 10 of 13 cases by a mean of 100 days. The difference between early and late CC groups as to the frequency of the extensive cGvHD was statistically significant (P<0.001). Also, there was a significant correlation of the time of CC and time between CC and cGvHD. Additionally, patients with early CC developed significantly more severe cGvHD measured by the need of three-drug treatment to control the disease (P<0.005). It can be concluded that achievement of early complete donor hematopoietic chimerism in peripheral blood is strongly predictive of severe extensive GvHD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Antin JH, Childs R, Filipovich AH et al. Establishment of complete and mixed donor chimerism after allogenic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 tandem meetings. Biol Blood Marrow Transplant 2001; 7: 473–485.

    Article  CAS  PubMed  Google Scholar 

  2. Huss R, Deeg HJ, Gooley T et al. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia. Bone Marrow Transplant 1996; 18: 767–776.

    CAS  PubMed  Google Scholar 

  3. Chalandon Y, Vischer S, Helg C et al. Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Geneva experience. Leukemia 2003; 17: 228–231.

    Article  CAS  PubMed  Google Scholar 

  4. Khan F, Agarwal A, Agrawal S . Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme. Bone Marrow Transplant 2004; 34: 1–12.

    Article  CAS  PubMed  Google Scholar 

  5. Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclopsporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314: 729–735.

    Article  CAS  PubMed  Google Scholar 

  6. Przepiorka D, Weisdorf D, Martin P et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825–828.

    CAS  PubMed  Google Scholar 

  7. Schulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long term clinicopathologic study of 20 Seatle patients. Am J Med 1980; 69: 204–217.

    Article  Google Scholar 

  8. Gardiner N, Lawler M, O'Riordan J et al. Persistent donor chimaerism is consistent with disease-free survival following BMT for chronic myeloid leukaemia. Bone Marrow Transplant 1997; 20: 235–241.

    Article  CAS  PubMed  Google Scholar 

  9. Schattenberg A, De Witte T, Salden M et al. Mixed hematopoietic chimerism after allogenic transplantation with lymphocyte-depleted bone marrow is not associated with a higher incidence of relapse. Blood 1989; 74: 1367–1372.

    Google Scholar 

  10. Mangioni S, Balduzzi A, Rivolta A et al. Long-term persistence of hemopoietic chimerism following sex-mismatched bone marrow transplantataion. Bone Marrow Transplant 1996; 20: 969–973.

    Article  Google Scholar 

  11. Molloy K, Goulden N, Lawler M et al. Patterns of hematopoietic chimerism following bone marrow transplantation for childhood acute lymphoblastic leukemia from volunteer unrelated. Blood 1996; 87: 3027–3031.

    CAS  PubMed  Google Scholar 

  12. Dubovsky J, Daxberger H, Fritsch G et al. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection. Leukemia 1999; 13: 2059–2069.

    Article  CAS  PubMed  Google Scholar 

  13. Colson YL, Boggs SS, Patrene KD, Ildstad ST . Durable mixed allogenic chimerism and tolerance by a normal radiation-based cytoreductive approach. J Transplant 1996; 157: 2828–2829.

    Google Scholar 

  14. Wekerle TH, Blaha P, Asari R et al. Tolerance induction through mixed chimerism. Eur Surg 2002; 34: 131–136.

    Article  Google Scholar 

  15. Schaap N, Schattenberg A, Mensink E et al. Long-term follow-up of persisting mixed chiemrism after partially T cell-depleted allogenic stem cell transplantation. Leukemia 2002; 16: 13–21.

    Article  CAS  PubMed  Google Scholar 

  16. Umemura A, Morita H, Li XC et al. Dissociation of hemopoetic chimerism and allograft tolerance after allogenic bone marrow transplantation. J Immunol 2001; 167: 3043–3048.

    Article  CAS  PubMed  Google Scholar 

  17. Mapara MY, Kim YK, Wang S et al. Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogenic chimeras: a critical role for host antigen-presenting cells. Blood 2002; 100: 1903–1909.

    Article  CAS  PubMed  Google Scholar 

  18. Sykes M, Sachs DH . Mixed chimerism. Philos Trans Roy Soc London B 2001; 1409: 707–726.

    Article  Google Scholar 

  19. Chakrabaratti S, Handa SK, Bryon RJ et al. Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant. Transplantation 2001; 72: 340–342.

    Article  Google Scholar 

  20. Wren SM, Hronakes ML, Iidstad ST . CD4+ T cells, but not CD8+ T cells, mediate the breaking of tolerance in mixed allogenic chimeras (B10+B10.BR → B10). Transplantation 1993; 55: 1382–1389.

    Article  CAS  PubMed  Google Scholar 

  21. Imammura M, Tsutsumi Y, Miura Y et al. Immune reconstitution and tolerance after allogenic hematopoietic stem cell transplantation. Hematology 2003; 8: 19–26.

    Article  Google Scholar 

  22. Toh HC, Spitzer TR, Preffer F et al. Fluctuating lymphoctes chimerism, tolerance and anti-tumor response in patient with refractory lymphoma receiving nonmyeloalative conditioning and a haploidentical related allogeneic bone marrow transplant. Cytokines Cell Mol Ther 2002; 7: 43–47.

    Article  PubMed  Google Scholar 

  23. Lion T, Daxberger H, Dubovsky J et al. Analysis of chimerism within specific leukocyte subsets for detection of residual or recurrent leukemia in pediatric patients with allogenic stem cell transplantation. Leukemia 2001; 15: 307–310.

    Article  CAS  PubMed  Google Scholar 

  24. Winiarski J, Gustafsson A, Wester D, Dalianis T . Follow-up of chimerism, including T- and B-lymphocytes and granulocytes in children more than one year after allogenic marrow transplantation. Pediatr Transplant 2000; 4: 132–139.

    Article  CAS  PubMed  Google Scholar 

  25. Chabannom C, Lafage M, Mozziconacci MJ et al. Early establishment of chimerism in the B and T lymphoid lineages after transplanatation of allogenic mobilized blood cells in leukemic patients. Transplantation 1997; 63: 1646–1652.

    Article  Google Scholar 

Download references

Acknowledgements

The research was supported by grant from the State Committee of Scientific Research 4PO5BO4419 (Poland).

Author information

Authors and Affiliations

  1. Department of Haematology, Medical University School of Gdańsk, Poland

    J Balon, K Hałaburda, M Bieniaszewska, A Piekarska & A Hellmann

  2. Department of Forensic Medicine, Medical University School of Gdańsk, Poland

    M Reichert & R Pawłowski

  3. Department of Hypertension and Diabetology, Medical University School of Gdańsk, Poland

    L Bieniaszewski

  4. Institute of Forensic Research, Krakow, Poland

    R Pawłowski

Authors
  1. J Balon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K Hałaburda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Bieniaszewska
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Reichert
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L Bieniaszewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A Piekarska
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R Pawłowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A Hellmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J Balon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Balon, J., Hałaburda, K., Bieniaszewska, M. et al. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease. Bone Marrow Transplant 35, 1083–1088 (2005). https://doi.org/10.1038/sj.bmt.1704962

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704962

Keywords

This article is cited by

Search

Advanced search

Quick links